Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yamashita Health Care Holdings's quarterly market cap
increased
from Aug. 2025 (円7,722 Mil) to Nov. 2025 (円8,124 Mil) and
increased
from Nov. 2025 (円8,124 Mil) to Feb. 2026 (円9,395 Mil).
Yamashita Health Care Holdings's annual market cap
declined
from May. 2024 (円6,653 Mil) to May. 2025 (円6,409 Mil) but then
increased
from May. 2025 (円6,409 Mil) to May. 2026 (円7,803 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Yamashita Health Care Holdings's Enterprise Value for Today is 円4,528 Mil.
Yamashita Health Care Holdings (TSE:9265) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Yamashita Health Care Holdings Market Cap Related Terms
Yamashita Health Care Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Yamashita Health Care Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's Market Cap falls into.
Yamashita Health Care Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a Market Cap of 円8,655 Mil as of Aug. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yamashita Health Care Holdings and its competitors. According to the industry distribution chart, Yamashita Health Care Holdings ranks #78 out of 121 companies in the Medical Distribution industry, placing it in the top 64.5%.
Is Yamashita Health Care Holdings' Market Cap too high?
Yamashita Health Care Holdings' current Market Cap is 円8,655 Mil. Based on the distribution chart, Yamashita Health Care Holdings ranks #78 out of 121 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #78 out of 121 companies for Market Cap. This places Yamashita Health Care Holdings in the lower half of its industry. The industry median Market Cap is 143.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 143.55, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median Market Cap is 143.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current Market Cap is 円8,655 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,400.00 — trading 15.1% above its estimated fair value. The current Market Cap is 円8,655 Mil. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current Market Cap is 円8,655 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,400.00 is trading 15.1% above its estimated GF Value™ of 円2,955.01.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
Market Cap: 円8,655 Mil
GF Value™: 円2,955.01 vs. price of 円3,400.00 (15.1% above fair value)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score
Get the complete analysis for TSE:9265
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
